DICE regimen
|
WikiDoc Resources for DICE regimen |
|
Articles |
|---|
|
Most recent articles on DICE regimen Most cited articles on DICE regimen |
|
Media |
|
Powerpoint slides on DICE regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on DICE regimen at Clinical Trials.gov Clinical Trials on DICE regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on DICE regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on DICE regimen Discussion groups on DICE regimen Patient Handouts on DICE regimen Directions to Hospitals Treating DICE regimen Risk calculators and risk factors for DICE regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for DICE regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
DICE regimen refers to a regimen consisting of dexamethasone, isofosfamide, cisplatin, and etoposide regimen used to treat on recurrent and refractory Non Hodgkins lymphoma.[1]
Regimen
Ddexamethasone
Iisofosfamide
CCisplatin
Eetoposide
Indications
References
- ↑ 1.0 1.1 Bo LJ, Liang AB, Liu B, Chen YH, Wang F, Jin XP (2006). "[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma]". Ai Zheng. 25 (12): 1553–6. PMID 17166385.